Square Enix Co., Ltd.

Showa University

Tms Company LLC

Biogen Ma Inc.

Tokyo University of Agriculture and Technology

Ji Xing Pharmaceuticals Hong Kong Limited

National University Corporation Tokyo University of Agriculture and Technology

Keita Shibata

Terumasa Hashimoto

Keiji Hasumi

Keiko Hasegawa

Kazuo Honda

Makoto Tsuda

Manami Fushiki

Honda Kazuo

Koji Nobe

A drug for renal disease, the drug including a compound represented by the following Formula (I) as an active ingredient.

Drug and method of treating or preventing renal disease using drug

Provided is a non-transitory computer readable medium including an object linking program causing a server to implement, in a case where one of a real space and a virtual space augmented from the real space is a first space, and the other is a second space, a change information obtaining function of obtaining change information indicating a change in parameter or form of a first object in the first space, and a change linking processing function of performing a process causing a parameter or a form of one or more second objects in the second space to correspond to the first object after change based on the change information.

Non-transitory computer readable medium including object linking program and object linking system

A non-transitory computer readable medium including an augmented reality processing program causing a server to implement a controllable object display data output function of outputting display data for displaying, in a superimposed manner on a real space, a controllable object that is a virtual object controllable by a user, and a controllable object control function of controlling at least one of an operation, movement, and a state change of the controllable object in accordance with an operation input provided by the user.

Non-transitory computer readable medium including augmented reality processing program and augmented reality processing system

Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is &#x2014;CHY&#x2014;C(CH)Z, Y and Z are each independently &#x2014;H or &#x2014;OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.

Cytoprotective agent

Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is &#x2014;CHY&#x2014;C(CH)Z, Y and Z are each independently &#x2014;H or &#x2014;OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less. 

Growing community of inventors

Tokyo, Japan

Keita Shibata